ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,001 filers reported holding ASTRAZENECA PLC in Q2 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $221,798,169 | -30.1% | 3,275,224 | -26.1% | 0.05% | -27.7% |
Q2 2023 | $317,234,598 | +87.8% | 4,432,508 | +82.1% | 0.06% | +80.6% |
Q1 2023 | $168,964,138 | -9.6% | 2,434,291 | -11.4% | 0.04% | -23.4% |
Q4 2022 | $186,979,532 | +45.2% | 2,746,158 | +17.1% | 0.05% | +42.4% |
Q3 2022 | $128,732,000 | -5.6% | 2,344,599 | +14.9% | 0.03% | -2.9% |
Q2 2022 | $136,401,000 | -31.9% | 2,041,036 | -31.7% | 0.03% | 0.0% |
Q1 2022 | $200,423,000 | -55.4% | 2,990,219 | -61.1% | 0.03% | +142.9% |
Q4 2021 | $449,024,000 | -5.8% | 7,685,952 | -3.2% | 0.01% | -78.1% |
Q3 2021 | $476,666,000 | +67.0% | 7,936,497 | +67.2% | 0.06% | +60.0% |
Q2 2021 | $285,488,000 | -32.1% | 4,746,078 | -43.6% | 0.04% | -40.3% |
Q1 2021 | $420,397,000 | -56.9% | 8,418,761 | -56.7% | 0.07% | -15.2% |
Q4 2020 | $974,572,000 | +82.2% | 19,442,366 | +99.2% | 0.08% | -23.3% |
Q3 2020 | $534,784,000 | +152.8% | 9,758,857 | +144.0% | 0.10% | +106.0% |
Q2 2020 | $211,529,000 | +208.9% | 3,999,395 | +160.8% | 0.05% | +127.3% |
Q1 2020 | $68,482,000 | +33.3% | 1,533,407 | +48.8% | 0.02% | +46.7% |
Q4 2019 | $51,385,000 | +20.1% | 1,030,600 | +7.4% | 0.02% | 0.0% |
Q3 2019 | $42,769,000 | -60.9% | 959,600 | -63.8% | 0.02% | +7.1% |
Q2 2019 | $109,398,000 | +170.5% | 2,650,173 | +164.9% | 0.01% | -17.6% |
Q1 2019 | $40,440,000 | -21.8% | 1,000,259 | -26.5% | 0.02% | -15.0% |
Q4 2018 | $51,707,000 | -51.9% | 1,361,427 | -49.9% | 0.02% | -42.9% |
Q3 2018 | $107,485,000 | +118.4% | 2,716,317 | +93.8% | 0.04% | +94.4% |
Q2 2018 | $49,209,000 | -31.8% | 1,401,580 | -32.1% | 0.02% | -30.8% |
Q1 2018 | $72,141,000 | -12.3% | 2,062,904 | -13.0% | 0.03% | -10.3% |
Q4 2017 | $82,271,000 | -8.4% | 2,370,900 | -10.5% | 0.03% | -14.7% |
Q3 2017 | $89,793,000 | -63.1% | 2,650,325 | -62.8% | 0.03% | -68.2% |
Q2 2017 | $243,065,000 | +56.9% | 7,130,084 | +43.4% | 0.11% | +37.2% |
Q1 2017 | $154,881,000 | +78.5% | 4,973,705 | +56.6% | 0.08% | +81.4% |
Q4 2016 | $86,775,000 | +133.0% | 3,176,226 | +180.2% | 0.04% | +138.9% |
Q3 2016 | $37,244,000 | +16.2% | 1,133,400 | +6.8% | 0.02% | +5.9% |
Q2 2016 | $32,040,000 | +49.9% | 1,061,284 | +39.9% | 0.02% | +54.5% |
Q1 2016 | $21,370,000 | -50.7% | 758,831 | -40.5% | 0.01% | -45.0% |
Q4 2015 | $43,325,000 | -3.1% | 1,276,165 | -9.2% | 0.02% | +5.3% |
Q3 2015 | $44,704,000 | -28.9% | 1,404,895 | +42.4% | 0.02% | -29.6% |
Q2 2015 | $62,834,000 | +10.5% | 986,268 | +18.7% | 0.03% | +3.8% |
Q1 2015 | $56,840,000 | -81.3% | 830,625 | -80.8% | 0.03% | -78.5% |
Q4 2014 | $304,533,000 | -12.0% | 4,326,993 | -10.7% | 0.12% | -9.0% |
Q3 2014 | $346,016,000 | +33.1% | 4,843,450 | +38.5% | 0.13% | +18.8% |
Q2 2014 | $259,933,000 | +527.2% | 3,497,943 | +447.6% | 0.11% | +489.5% |
Q1 2014 | $41,441,000 | -9.1% | 638,737 | -16.9% | 0.02% | -13.6% |
Q4 2013 | $45,608,000 | +45.0% | 768,200 | +26.8% | 0.02% | +29.4% |
Q3 2013 | $31,462,000 | +14.9% | 605,852 | +4.7% | 0.02% | +6.2% |
Q2 2013 | $27,378,000 | – | 578,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |